Optimising the Delivery of Diabetes Distress Informed Care for Its Prevention, Detection, and Management in Adults With Type 1 Diabetes: a Feasibility Study (D-stress Study)
NCT ID: NCT07193446
Last Updated: 2025-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
110 participants
INTERVENTIONAL
2025-10-31
2026-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the UK, the NHS needs to better understand how to best support people feeling emotionally burdened by diabetes. So, we have worked with diabetes distress specialists around the world to develop an NHS pathway to care for diabetes distress. This pathway to care involves training diabetes teams to recognise, assess and talk about diabetes distress at routine appointments. If people have a high diabetes distress level, they may be able to take part in an online group program to help them manage their type 1 diabetes and emotions. The feasibility study will test this pathway to care with people with type 1 diabetes in the NHS setting.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot of Pragmatic Delivery of Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes
NCT06405386
Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART
NCT06405373
Use of an Online Intervention for the Treatment of Diabetes Distress in Patients With Type 1-Diabetes
NCT06436456
Reducing Distress And Improving Glycemic Control In Adults With Type 1 Diabetes
NCT02175732
Resilience Promotion in Teens With Type 1 Diabetes: Preventing Negative Outcomes
NCT01490619
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Enhanced Usual Care (EUC)
This arm of the study involves health care professionals e-learning training in and delivery of EUC for the detection and management of diabetes distress.
D-stress study: The detection, prevention and management of diabetes distress for adults living with type 1 diabetes.
Enhanced Usual Care intervention aims to train health care professionals to detect and prevent, and manage diabetes distress in routine diabetes care, in the UK NHS. The REDUCE programme aims to prevent and manage elevated diabetes distress.
REDUCE Programme Intervention
REDUCE intervention is an online group 6 session programme for the management of elevated diabetes distress.
D-stress study: The detection, prevention and management of diabetes distress for adults living with type 1 diabetes.
Enhanced Usual Care intervention aims to train health care professionals to detect and prevent, and manage diabetes distress in routine diabetes care, in the UK NHS. The REDUCE programme aims to prevent and manage elevated diabetes distress.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
D-stress study: The detection, prevention and management of diabetes distress for adults living with type 1 diabetes.
Enhanced Usual Care intervention aims to train health care professionals to detect and prevent, and manage diabetes distress in routine diabetes care, in the UK NHS. The REDUCE programme aims to prevent and manage elevated diabetes distress.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* People aged 18 years old and older
* With a T1DM diagnosis of more than one year
* Who used a Continuous Glucose Monitoring device 3 months prior to trial entry
Health care professionals
* Members of the multidisciplinary diabetes team
* Who would like and be able to undertake training in Enhanced Usual Care (EUC)
Family or friend
* People aged 18 years or older
* Is involved with the care of the participant
* The participant has consented to the family member or friend to be involved in the study
REDUCE Facilitators
• Eligibility as per the role specification in Section 6.2.2 of study Protocol
Exclusion Criteria
* Women who are pregnant. This is because the additional burdens and anxieties this population is confronted with may risk confounding the trial findings
* Exclusion of adults with current mental health diagnoses with current symptoms (e.g. psychosis or substance abuse or severe depression), will be evaluated and determined on a case-by-case basis by clinical care teams.
Health care professionals • People who are unwilling or unable to take on additional workload associated with D-stress e-learning and delivery of Enhanced Usual Care.
Family or friend
• Participant with type 1 diabetes has not given consent for a family member or friend to participate in the study
REDUCE Facilitators
* • Professional accreditation with one of the following professional bodies: Nursing \& Midwifery Council, Health \& Care Professionals Council, British Association for Counselling \& Psychotherapy, and UK Council for Psychotherapy.
* Professional or personal understanding of Type 1 diabetes
* Professional or personal understanding of NHS diabetes care and guidelines
* Professional or personal understanding of diabetes distress
* Professional understanding of mental and emotional health
* Professional experience of in-person and/or online group facilitation especially in managing diverse needs within a group and the expression of strong emotions
* Willingness to be a research participant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Guy's and St Thomas' NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal United Hospitals Bath
Bath, , United Kingdom
University Hospitals Leicester NHS Trust
Leicester, , United Kingdom
Guy's and St Thomas' Hospitals NHS Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PGfAR NIHR205441
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
349849
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.